209 related articles for article (PubMed ID: 22989209)
21. Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage.
Bel Feki N; Zayet S; Ben Ghorbel I; Houman MH
J Mal Vasc; 2016 Dec; 41(6):403-406. PubMed ID: 27743753
[TBL] [Abstract][Full Text] [Related]
22. [Lupus anticoagulant-hypoprothrombinemia syndrome revealing systemic lupus in an 11-year old girl in a context of clinical and biological emergency].
Favier R; Kheyar T; Renolleau S; Tabone MD; Favier M; Ulinski T
Ann Biol Clin (Paris); 2012; 70(2):226-30. PubMed ID: 22484537
[TBL] [Abstract][Full Text] [Related]
23. Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis.
Lipari A; Sorrentino S; Tamburini C; Castaman G; Prisco D; De Candia E
Intern Emerg Med; 2023 Jun; 18(4):1233-1238. PubMed ID: 37165299
[No Abstract] [Full Text] [Related]
24. Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome.
Jimenez AR; Vallejo ES; Cruz MZ; Cruz AC; Miramontes JV; Jara BS
Lupus; 2013 Dec; 22(14):1514-7. PubMed ID: 23989733
[TBL] [Abstract][Full Text] [Related]
25. [Refractory subacute cutaneous lupus erythematosus treated with rituximab].
Cieza-Díaz DE; Avilés-Izquierdo JA; Ceballos-Rodríguez C; Suárez-Fernández R
Actas Dermosifiliogr; 2012; 103(6):555-7. PubMed ID: 22482740
[No Abstract] [Full Text] [Related]
26. [Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors].
Morinaga S; Ide Y; Kusumoto M; Ogata M; Takaki K; Matsumoto E
Rinsho Ketsueki; 2012 Jul; 53(7):716-20. PubMed ID: 22975775
[TBL] [Abstract][Full Text] [Related]
27. [Combined hypoprothrombinemia-antiphospholipid syndrome in a patient suffering from lupus].
Sellami M; Elloumi M; Fourati H; Ayadi N; Baklouti S
Presse Med; 2004 Mar; 33(6):391. PubMed ID: 15105782
[No Abstract] [Full Text] [Related]
28. Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature.
Erre GL; Pardini S; Faedda R; Passiu G
Lupus; 2008 Jan; 17(1):50-5. PubMed ID: 18089684
[TBL] [Abstract][Full Text] [Related]
29. Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER).
Merrill J; Buyon J; Furie R; Latinis K; Gordon C; Hsieh HJ; Brunetta P
Lupus; 2011 Jun; 20(7):709-16. PubMed ID: 21478286
[TBL] [Abstract][Full Text] [Related]
30. Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
Matsukura S; Knowles SR; Walsh S; Shear NH
Arch Dermatol; 2012 Jun; 148(6):734-9. PubMed ID: 22351790
[TBL] [Abstract][Full Text] [Related]
31. Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature.
Erkan D; Bateman H; Lockshin MD
Lupus; 1999; 8(7):560-4. PubMed ID: 10483036
[TBL] [Abstract][Full Text] [Related]
32. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.
Erkan D; Vega J; Ramón G; Kozora E; Lockshin MD
Arthritis Rheum; 2013 Feb; 65(2):464-71. PubMed ID: 23124321
[TBL] [Abstract][Full Text] [Related]
33. Lupus Anticoagulant-Hypoprothrombinemia syndrome (HLAS): report of one case in a familial infectious context.
Appert-Flory A; Fischer F; Amiral J; Monpoux F
Thromb Res; 2010 Aug; 126(2):e139-40. PubMed ID: 20006899
[No Abstract] [Full Text] [Related]
34. Hypoprothrombinemia
Cai W; Shen J; Ma L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1775-1778. PubMed ID: 38432870
[TBL] [Abstract][Full Text] [Related]
35. Rituximab therapy for recurrent thromboembolic disease in antiphospholipid syndrome.
Bakshi J; Stevens R
Lupus; 2013 Jul; 22(8):865-7. PubMed ID: 23740031
[No Abstract] [Full Text] [Related]
36. [Catastrophic antiphospholipid syndrome and rituximab: a new report].
Ketari Jamoussi S; Zaghdoudi I; Ben Dhaou B; Kochbati S; Mir K; Ben Ali Z; Boussema F; Cherif O; Rokbani LM
Tunis Med; 2009 Oct; 87(10):699-702. PubMed ID: 20187361
[TBL] [Abstract][Full Text] [Related]
37. A Chinese Boy With Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Case Report and Review of the Literature.
Chan EY; Leung KFS; Soo ETL; Ma ALT
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e445-e447. PubMed ID: 32287097
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG.
Umezawa N; Kohsaka H; Nanki T; Watanabe K; Tanaka M; Shane PY; Miyasaka N
Mod Rheumatol; 2014 Jul; 24(4):685-7. PubMed ID: 24517553
[TBL] [Abstract][Full Text] [Related]
39. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
40. Lupus Anticoagulant-Hypoprothrombinemia Syndrome and Pseudotumor Cerebri as an Initial Presentation of Systemic Lupus Erythematosus in a 16-Year-Old Male Patient: A Case Report and Literature Review.
Omer MH; Salama H; Alghaythi AM; Alharbi AA; AlJohani G
Am J Case Rep; 2022 Oct; 23():e938051. PubMed ID: 36207805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
